Login to Your Account



U.S. Patent Disclosures


Friday, April 13, 2012
• Ariad Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No. 8,114,874, titled "Substituted Acetylenic Imidazo[1,2-B] Pyridazine Compounds as Kinase Inhibitors." It provides composition-of-matter protection for investigational pan-Bcr-Abl inhibitor ponatinib.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription